|
Accretion Pharmaceuticals Ltd. has announced public offering of 2946000 shares at a price of Rs 10.00 each for Cash at a Premium of Rs 91.00 per share. The gross proceeds of the issue are expected to be Rs 2,975.46 lakhs.
The company's initial public offer (IPO) will open on 14 May 2025 and is expected to close on 16 May 2025, subject to customary closing conditions. The price band of the issue has been fixed at Rs 96.00-101.00 per share.
The IPO includes a fresh Issue of 2946000 Equity Shares of the Company at an price of Rs 101.00 per Equity Share. The company has fixed the minimum bid lot for the issue at 1200 shares with bids in multiples of 1200.
Accretion Pharmaceuticals Ltd. anticipates using the proceeds of the issue for .
Jawa Capital Services Pvt. Ltd. as lead manager & KFin Technologies Ltd. is the registrar, to the issue.
|